Investigators analyzed exfoliated cells in urine test specimens to identify 50 candidate RNAs for prostate cancer detection.

Belimumab is linked to a reduced risk for all-cause mortality compared with azathioprine, methotrexate, and mycophenolate among patients with nonrenal SLE.

Akebia Therapeutics has decided not to initiate a clinical trial assessing vadadustat in patients with late-stage CKD not on dialysis.

Topline data were announced from a phase 3 trial evaluating obinutuzumab in adults with systemic lupus erythematosus on standard therapy.